Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

PLD is an effective and safer alternative for treating breast cancer.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Platelet-rich plasma might help tissue regeneration in dentistry, but results vary and more research is needed.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Red light therapy is safe and effectively increases hair growth in women with hair loss.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.